Local Institution - 0140

Beijing, Beijing Municipality 100191

1 studies enrolling now · 3 studies all time

What they study most

Hepatocellular Carcinoma, Plaque Psoriasis, Prostate Cancer

Studies at this site

• Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK) — Recruiting now
• A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer — Completed
• An Investigational Immuno-therapy Study of Nivolumab Compared to Sorafenib as a First Treatment in Patients With Advanced Hepatocellular Carcinoma — Completed